Literature DB >> 23636290

Splicing: hear and now!

Ryszard Kole1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23636290      PMCID： PMC3666642          DOI： 10.1038/mt.2013.75

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  8 in total

Review 1.  Cell- and gene-therapy approaches to inner ear repair.

Authors:  M M Conde de Felipe; A Feijoo Redondo; J García-Sancho; T Schimmang; M B Durán Alonso
Journal:  Histol Histopathol       Date:  2011-07       Impact factor: 2.303

2.  Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.

Authors:  Rosie Z Yu; Kristina M Lemonidis; Mark J Graham; John E Matson; Rosanne M Crooke; Diane L Tribble; Mark K Wedel; Arthur A Levin; Richard S Geary
Journal:  Biochem Pharmacol       Date:  2008-11-14       Impact factor: 5.858

3.  Systemic administration of PRO051 in Duchenne's muscular dystrophy.

Authors:  Nathalie M Goemans; Mar Tulinius; Johanna T van den Akker; Brigitte E Burm; Peter F Ekhart; Niki Heuvelmans; Tjadine Holling; Anneke A Janson; Gerard J Platenburg; Jessica A Sipkens; J M Ad Sitsen; Annemieke Aartsma-Rus; Gert-Jan B van Ommen; Gunnar Buyse; Niklas Darin; Jan J Verschuuren; Giles V Campion; Sjef J de Kimpe; Judith C van Deutekom
Journal:  N Engl J Med       Date:  2011-03-23       Impact factor: 91.245

4.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Authors:  Sebahattin Cirak; Virginia Arechavala-Gomeza; Michela Guglieri; Lucy Feng; Silvia Torelli; Karen Anthony; Stephen Abbs; Maria Elena Garralda; John Bourke; Dominic J Wells; George Dickson; Matthew J A Wood; Steve D Wilton; Volker Straub; Ryszard Kole; Stephen B Shrewsbury; Caroline Sewry; Jennifer E Morgan; Kate Bushby; Francesco Muntoni
Journal:  Lancet       Date:  2011-07-23       Impact factor: 79.321

5.  Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.

Authors:  Claus Zehetner; Rudolf Kirchmair; Stefan Huber; Martina T Kralinger; Gerhard F Kieselbach
Journal:  Br J Ophthalmol       Date:  2013-02-05       Impact factor: 4.638

6.  Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.

Authors:  Z Dominski; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 7.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides.

Authors:  Ryszard Kole; Adrian R Krainer; Sidney Altman
Journal:  Nat Rev Drug Discov       Date:  2012-01-20       Impact factor: 84.694

8.  Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.

Authors:  Jennifer J Lentz; Francine M Jodelka; Anthony J Hinrich; Kate E McCaffrey; Hamilton E Farris; Matthew J Spalitta; Nicolas G Bazan; Dominik M Duelli; Frank Rigo; Michelle L Hastings
Journal:  Nat Med       Date:  2013-02-04       Impact factor: 53.440
  8 in total
  1 in total

1.  NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.

Authors:  Ruihui Xie; Xu Chen; Liang Cheng; Ming Huang; Qianghua Zhou; Jingtong Zhang; Yuelong Chen; Shengmeng Peng; Ziyue Chen; Wen Dong; Jian Huang; Tianxin Lin
Journal:  Mol Ther       Date:  2020-09-05       Impact factor: 11.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.